Heterocyclic Compounds as Kinase Inhibitors, Compositions Comprising the Heterocyclic Compound, and Methods of Use Thereof
Copyright © Targeted News Service 2024
2024-11-05
ALEXANDRIA, Virginia, Nov. 5 -- JS INNOMED HOLDINGS LTD., Grand Cayman, Cayman Islands has been assigned a patent (No. US 12133841 B2, initially filed May 20, 2019) developed by five inventors Qun Li, Sunnyvale, California; Jintao Zhang, Naperville, Illinois; Shanzhong Jian, Shanghai, China; Wen Xu, Shanghai, China; and Ao Li, Shanghai, China, for "Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof." . . .